Recombinant Mouse B7-H2 (ICOSL)
BackgroundB7-H2, also known as ICOSL and B7RP-1, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains. B7-H2 is expressed on B cells and macrophages. It binds to ICOS on activated T cells and thus delivers a positive costimulatory signal for optimal T cell function (1). ICOS and B7RP-I do not interact with proteins in the CD28-B7 pathway (2). The structural features of B7-H2 are crucial for its costimulatory function. B7-H2 constructs lacking either the IgC or IgV domain demonstrates that receptor binding is mediated solely by the IgV domain but requires the IgC domain for maintaining the structural integrity of the protein (3). Protein DetailsPurity >95% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Fusion Protein Tag Fc Fusion Protein Protein Accession No. Amino Acid Sequence etev gamvgsnvvl scidphrrhf nlsglyvywq ienpevsvty ylpykspgin vdssyknrgh lsldsmkqgn fslylknvtp qdtqeftcrv fmntatelvk ileevvrlrv aanfstpvis tsdssnpgqe rtytcmskng ypepnlywin ttdnslidta lqnntvylnk lglydvistl rlpwtsrgdv lccvenvalh qnitsisqae sftgnntknp qethnnelkd iegrmdpksc dkthtcppcp apellggpsv flfppkpkdt lmisrtpevt cvvvdvshed pevkfnwyvd gvevhnaktk preeqynsty rvvsvltvlh qdwlngkeyk ckvsnkalpa piektiskak gqprepqvyt lppsrdeltk nqvsltclvk gfypsdiave wesngqpenn ykttppvlds dgsfflyskl tvdksrwqqg nvfscsvmhe alhnhytqks lslspgk
N-terminal Sequence Analysis Glu47 State of Matter Lyophilized Predicted Molecular Mass The predicted molecular weight of Recombinant Mouse B7-H2 is Mr 53 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 80-90 kDa. Predicted Molecular Mass 53 Formulation This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives. Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Next Day Ambient NCBI Gene Bank Leinco Protein AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Recombinant mouse B7-H2 (ICOSL) is a valuable tool for immunological research due to its critical role in T cell costimulation and its well-characterized functional properties. Functional SignificanceB7-H2 serves as a ligand for the inducible costimulator (ICOS), a CD28 family receptor expressed on activated T cells. When B7-H2 binds to ICOS on T cells, it delivers a potent costimulatory signal that enhances T cell proliferation and cytokine production. This interaction is distinct from the classical B7-1/B7-2-CD28 pathway, as B7-H2 uses overlapping but differential binding domains to interact with ICOS versus CD28 and CTLA-4. Research ApplicationsThe recombinant mouse B7-H2 protein enables several important experimental approaches: T Cell Activation Studies: The protein can be used to investigate T cell proliferation and activation in response to costimulatory signals. When immobilized or presented as an Fc chimera, recombinant B7-H2 stimulates anti-CD3-induced T cell proliferation in a dose-dependent manner. Cytokine Production Analysis: B7-H2 costimulation preferentially induces specific cytokine profiles compared to B7-1. While B7-1 generates high amounts of IL-2, B7-H2 appears to induce more IL-17A and can enhance IL-10 production through ICOS engagement. This makes it useful for studying Th1, Th2, and regulatory T cell responses. Survival Signal Investigation: B7-H2-CD28 interaction provides crucial signals for enhancing Bcl-xL expression in activated CD4+ T cells, making it valuable for studying T cell survival mechanisms. Immune Checkpoint Research: Since ICOS/ICOS-L signaling plays roles in both anti-tumor and pro-tumor immune responses, recombinant B7-H2 is applicable for investigating immune checkpoint biology and potential therapeutic combinations. Technical AdvantagesThe recombinant protein typically exhibits high purity (>95% by SDS-PAGE) and maintains bioactivity suitable for functional assays. It is available in various formats, including Fc chimera constructs that facilitate immobilization and presentation to T cells. The lyophilized formulation provides stability for extended storage at -20°C to -70°C. Yes, recombinant mouse B7-H2 (ICOSL) can be used as a standard for quantification and calibration in ELISA assays. This protein is specifically designed and validated for this application across multiple experimental platforms. Primary Applications as an ELISA StandardRecombinant mouse B7-H2 serves as a calibration standard to establish standard curves for quantifying endogenous B7-H2 levels in biological samples. The protein enables accurate determination of sample concentrations by providing known reference points across a range of concentrations. For example, commercial ELISA kits utilizing this protein demonstrate assay ranges such as 39-2500 pg/mL, allowing researchers to quantify B7-H2 in their samples with defined sensitivity parameters. Formulation ConsiderationsWhen selecting recombinant B7-H2 for ELISA standardization, consider the formulation type: Proteins supplied with carrier proteins (such as bovine serum albumin) are recommended for use in cell or tissue culture applications and as ELISA standards. In contrast, carrier-free formulations are available for alternative applications but may require different handling considerations. Important LimitationA critical caveat exists regarding ELISA standard-grade recombinant proteins: they are not recommended for bioassay applications and have not been validated for functional assays. If your research requires both quantification via ELISA and functional characterization of B7-H2 activity, you should verify that your specific protein preparation has been tested for bioassay compatibility, as ELISA standard formulations are optimized for quantification purposes only. For optimal results, ensure your standard curve preparation follows established protocols with appropriate dilution buffers and includes sufficient sample replicates across the dynamic range of your assay. Recombinant Mouse B7-H2 (ICOSL) has been validated in published research for several key applications, primarily in studies of T cell costimulation, immune modulation, and protein-protein interaction assays. Validated Applications in Published Research:
Common Experimental Formats:
Summary Table of Applications
Key Insights:
If you require protocols or specific experimental details for any of these applications, please specify the intended use. To reconstitute and prepare Recombinant Mouse B7-H2 (ICOSL) protein for cell culture experiments, dissolve the lyophilized protein in sterile water or PBS to a concentration suitable for your assay, typically between 0.1–1.0 mg/mL. Use aseptic technique and include carrier protein (e.g., 0.1% BSA) if required for stability in cell-based assays. Step-by-step protocol:
Additional notes:
Summary Table:
This protocol ensures optimal solubility, stability, and biological activity of recombinant Mouse B7-H2 (ICOSL) for cell culture experiments. References & Citations1. Wiendl, H. et al. (2003) Brain 126:1026 2. Yoshinaga, SK. et al. (1999) Nature 402:827 3. Chattopadhyay, KJ. et al. (2006) Immunol. 177:3920 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
